Ardent Health, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $135.8M | $210.3M | $53.9M | $188.9M |
| Depreciation & Amortization | $155.7M | $146.3M | $140.8M | $138.2M |
| Depreciation | — | — | — | — |
| Amortization | $800.0K | — | — | — |
| Stock-Based Compensation | — | — | — | — |
| Net Cash from Operating Activities | $470.5M | $315.0M | $221.7M | $-38.4M |
| Investing Activities | ||||
| Capital Expenditures | — | — | — | — |
| Business Acquisitions | $2.5M | $35.5M | $0 | $0 |
| Net Cash from Investing Activities | $-214.2M | $-220.5M | $-138.0M | $46.6M |
| Financing Activities | ||||
| Dividends Paid | — | $0 | $0 | $174.8M |
| Stock Repurchases | — | — | — | — |
| Net Cash from Financing Activities | $-103.5M | $24.6M | $-102.3M | $-270.3M |
| Net Change in Cash | $152.8M | $119.2M | $-18.5M | $-262.1M |
| Free Cash Flow | — | — | — | — |